Latest News
Feature
Former pharma exec nominated for top HHS post
Alex Azar also served at HHS in the George W. Bush administration
Conference Coverage
Delay predicting outcome in comatose cardiac arrest
ANAHEIM, CALIF. – Three days after arrest is too soon to reliably prognosticate.
FDA/CDC
FDA approves Vimpat for POS treatment in children with epilepsy
The drug has previously been approved for use in adults.
News
MACRA Monday: Documenting current medications
Staying on top of a patient’s medication list could help you avoid a 4% MIPS penalty.
Conference Coverage
Unblinded data show extent of verubecestat’s failure in mild-moderate Alzheimer’s
BOSTON – No benefit was seen in any endpoint, in any subgroup.
Conference Coverage
Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis
BOSTON – Amyloid imaging can alleviate many of the difficulties in diagnosing some cases of dementia, and using florbetaben looks especially...
From the Journals
Public health hazard: Bring your flu to work day
Many physicians and pharmacists report working while having influenza-like illness.
Feature
MedPAC offers more details of MIPS replacement
WASHINGTON – The Medicare Payment Advisory Commission continues to mull the specifics of its proposed recommendation to scrap the Quality Payment...
Conference Coverage
Eliminating patient-controlled analgesia accelerates discharge after bariatric surgery
Study results suggest opioids may be largely avoided during recovery from bariatric surgery without any real disadvantages.
Feature
Docs to receive slightly better Medicare pay bump than originally proposed
Lack of funds leads prevents full Medicare pay increase.
Conference Coverage
New BACE1 study launches in the shadow of verubecestat’s demise
An ambitious new clinical trial will investigate a different BACE-inhibiting molecule as an Alzheimer’s preventive in people at high genetic risk...